Re: Prostate Cancer Mortality and Metastasis under Different Biopsy Frequencies in North American Active Surveillance Cohorts

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 204卷 / 02期
关键词：
D O I：
10.1097/JU.0000000000001115.01
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：387 / 387
页数：1
相关论文
共 50 条
  • [31] Exploring the relation of active surveillance schedules and prostate cancer mortality
    Yang, Zhenwei
    Heijnsdijk, Eveline A. M.
    Newcomb, Lisa F.
    Rizopoulos, Dimitris
    Erler, Nicole S.
    CANCER MEDICINE, 2024, 13 (05):
  • [32] How Often is Biopsy Necessary in Patients with Prostate Cancer on Active Surveillance?
    Bruinsma, S. M.
    Bokhorst, L. P.
    Roobol, M. J.
    Bangma, C. H.
    JOURNAL OF UROLOGY, 2016, 195 (01): : 11 - 12
  • [33] Re: African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from Canary Prostate Cancer Active Surveillance Study
    Powell, Isaac J.
    Heilbrun, Lance K.
    Kittles, Rick A.
    JOURNAL OF UROLOGY, 2021, 205 (02): : 338 - 339
  • [34] Staging saturation biopsy in patients with prostate cancer on active surveillance protocol
    Abouassaly, Robert
    Lane, Brian R.
    Jones, J. Stephen
    UROLOGY, 2008, 71 (04) : 573 - 577
  • [35] Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer
    Chang, Edward
    Jones, Tonye A.
    Natarajan, Shyam
    Sharma, Devi
    Simopoulos, Demetrios
    Margolis, Daniel J.
    Huang, Jiaoti
    Dorey, Frederick J.
    Marks, Leonard S.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 98 - 104
  • [36] Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer
    Detsky, Jay S.
    Ghiam, Alireza Fotouhi
    Mamedov, Alexandre
    Commisso, Kristina
    Commisso, Angela
    Zhang, Liying
    Liu, Stanley
    Klotz, Laurence
    Loblaw, Andrew
    Vesprini, Danny
    JOURNAL OF UROLOGY, 2020, 204 (05): : 934 - 940
  • [37] Risk of progression following a negative biopsy in prostate cancer active surveillance
    Kerri Beckmann
    Aida Santaolalla
    Mikio Sugimoto
    Peter Carroll
    Jose Rubio
    Arnauld Villers
    Anders Bjartell
    Todd Morgan
    Prokar Dasgupta
    Mieke Van Hemelrijck
    Oussama Elhage
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 403 - 409
  • [38] Risk of progression following a negative biopsy in prostate cancer active surveillance
    Beckmann, Kerri
    Santaolalla, Aida
    Sugimoto, Mikio
    Carroll, Peter
    Rubio, Jose
    Villers, Arnauld
    Bjartell, Anders
    Morgan, Todd
    Dasgupta, Prokar
    Van Hemelrijck, Mieke
    Elhage, Oussama
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) : 403 - 409
  • [39] Re: Role of Surveillance Biopsy with no Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 200 (01): : 30 - 30
  • [40] Active Surveillance of Prostate Cancer in African American Men REPLY
    Silberstein, Jonathan L.
    Sartor, Oliver A.
    UROLOGY, 2014, 84 (06) : 1262 - 1262
12345